Olanzapine Tablet
Product Images NDC 0832-6079

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0832-6079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Fig 1)

Fig-1 (Fig 1)
This text contains important information related to prescription medication storage guidelines. It indicates that the tablets should be stored at a temperature between 20° and 77°F, with excursions permitted from 15° to 30° (59° to 86°F). The text also emphasizes the need to protect the tablets from light and moisture, dispense them in a light-resistant container, and keep them tightly closed. Additionally, it directs pharmacists to provide the Medication Guide separately to each patient. The medicine is distributed by UPSHER-SMITH LABORATORIES, LLC, located in Maple Grove, MN 55369.*
FDA Label Image

Fig-2 (Fig 2)

Fig-2 (Fig 2)
This text is a description of Olanzapine tablets, USP, with a dosage of 5 mg per tablet. The usual dosage should be followed as per prescribing information. Storage instructions recommend keeping the tablets at a temperature between 20°C to 25°C (68°F to 77°F) and protecting them from light and moisture. The tablets should be dispensed in their original light-resistant container and should not be used if the inner seal is broken. It also emphasizes the importance of keeping all drugs out of the reach of children. The tablets are distributed by UPSHER-SMITH LABORATORIES, LLC, located in Maple Grove, MN 55369, and they are manufactured in China. The revision date for this information is 6/2024.*
FDA Label Image

Fig3 (Fig 3)

Fig3 (Fig 3)
This text is a description of a medication called Onzanine in tablet form, with a strength of 75 mg. It includes instructions for storage (at 20° to 25°C, protect from light and moisture, and dispense in a light-resistant container), a caution to keep out of reach of children, and details the distributor as Upsher-Smith Laboratories, LLC. The tablets come with a medication guide for each patient. The batch was made in China and has an expiration date of 6/2024.*
FDA Label Image

Fig-4 (Fig 4)

Fig-4 (Fig 4)
This is a medication information for Olanzapine tablets in 10mg strength. Each bottle contains 30 tablets. It is advised to store the tablets at a temperature range of 20°C to 25°C (68°F to 77°F). The medication should be protected from light and moisture, and dispensed in a tight, light-resistant container. It is important to keep the container closed tightly and out of reach of children. The tablets are distributed by UPSHER-SMITH LABORATORIES, LLC, based in Maple Grove, MN 55369.*
FDA Label Image

Fig-5 (Fig 5)

Fig-5 (Fig 5)
This text appears to be information about Olanzapine tablets, USP, with a strength of 15 mg. The medication guide should be provided separately to each patient. The tablets should be stored at a temperature range of 20° to 25°C (68 to 77°F) with excursions permitted between 15° to 30°C (59 to 86°F). They should be protected from light and moisture and dispensed in a light-resistant container. The tablets should be kept tightly closed and not used if the inner seal is broken. The information indicates that the drug is distributed by UPSHER-SMITH LABORATORIES, LLC, located in Maple Grove, MN, and the tablets are made in China. The expiration date is listed as June 2024.*
FDA Label Image

Fig-6 (Fig 6)

FDA Label Image

Image Description (Olanzapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.